Respiratory infections, Haemophilus, drugs for

Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).

Jacobs E, Dalhoff A, Korfmann G
Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study). [JOURNAL ARTICLE]
Int J Antimicrob Agents 2008 Sep 30.
Abstract | Full Citation

In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.

Seral C, Suárez L, Rubio-Calvo C, et al.
In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain. [JOURNAL ARTICLE]
Diagn Microbiol Infect Dis 2008 Aug 19.
Abstract | Full Citation

The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility.

Niki Y, Hanaki H, Yagisawa M, et al.
The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility. [Journal Article]
J Infect Chemother 2008 Aug; 14(4):279-90.
Abstract | Full Citation

Stimulation of Lung Innate Immunity Protects Against Lethal Pneumococcal Pneumonia in Mice.

Clement CG, Evans SE, Evans CM, et al.
Stimulation of Lung Innate Immunity Protects Against Lethal Pneumococcal Pneumonia in Mice. [JOURNAL ARTICLE]
Am J Respir Crit Care Med 2008 Apr 3.
Abstract | Full Citation | Publisher Full Text | Find Related Articles

Pharmacokinetics and pharmacodynamics of newer oral cephalosporins: implications for treatment of community-acquired lower respiratory tract infections.

Cazzola M, Matera MG, Donner CF
Pharmacokinetics and pharmacodynamics of newer oral cephalosporins: implications for treatment of community-acquired lower respiratory tract infections. [Journal Article]
Clin Drug Investig 1998; 16(4):335-46.
Abstract | Full Citation | Find Related Articles

Antimicrobial Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005/2006.

Zhanel GG, Decorby M, Laing N, et al.
Antimicrobial Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005/2006. [JOURNAL ARTICLE]
Antimicrob Agents Chemother 2008 Feb 19.
Abstract | Full Citation

Haemophilus influenzae type-b and non-b-type invasive diseases in urban children (<5years) of Bangladesh: Implications for therapy and vaccination.

Rahman M, Hossain S, Baqui AH, et al.
Haemophilus influenzae type-b and non-b-type invasive diseases in urban children (<5years) of Bangladesh: Implications for therapy and vaccination. [JOURNAL ARTICLE]
J Infect 2008 Feb 15; 56(3):191-196.
Abstract | Full Citation | Find Related Articles

Effect of Eucalyptus Essential Oil on Respiratory Bacteria and Viruses.

Cermelli C, Fabio A, Fabio G, et al.
Effect of Eucalyptus Essential Oil on Respiratory Bacteria and Viruses. [JOURNAL ARTICLE]
Curr Microbiol 2007 Oct 31.
Abstract | Full Citation | Publisher Full Text | Find Related Articles

[Investigation of Streptococcus pneumoniae and Haemophilus influenzae isolated from pediatric outpatients nationwide with a respiratory tract infection at the first consultation (2002-2003)--with special reference to the results of nasopharyngeal culture in pediatric patients with no previous history of antibacterial drug administration]

Oishi T, Sunakawa K
[Investigation of Streptococcus pneumoniae and Haemophilus influenzae isolated from pediatric outpatients nationwide with a respiratory tract infection at the first consultation (2002-2003)--with special reference to the results of nasopharyngeal culture in pediatric patients with no previous history of antibacterial drug administration] [English Abstract, Journal Article]
Kansenshogaku Zasshi 2007 Jul; 81(4):449-55.
Abstract | Full Citation | Find Related Articles

In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.

Mushtaq S, Warner M, Ge Y, et al.
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. [JOURNAL ARTICLE]
J Antimicrob Chemother 2007 Jun 4.
Abstract | Full Citation | Find Related Articles